ProterixBio Announces Commercial Offering of Quantitative Soluble ST2 Assay

/PRNewswire/ -- ProterixBio, Inc. today announced the offering of the Presage® ST2 Assay as a testing service through ProterixBio's high-complexity CLIA...

Related Keywords

Mississippi ,United States ,Christopher Bell ,Proterixbio Inc ,Consensus Panel ,Prnewswire Proterixbio Inc ,Cardiovascular Disease ,Acute Care Nurse Practitioner ,Cardiology Associates ,Family Member ,Clin Invest ,Myocardial Stress ,Chronic Heart ,Assay Kit ,Prognostic Value ,Serum Soluble ,Patients With Heart Failure ,Reduced Ejection Fraction ,Prospective Comparison ,Determine Impact ,Global Mortality ,Heart Failure ,Circ Heart ,Proterixbio ,Nc ,